Top

Published in:

01-01-2008 | Original Paper

Prospective Study of Attitudinal and Relationship Predictors of Sexual Risk in the Multicenter AIDS Cohort Study

Authors: David G. Ostrow, Michael J. Silverberg, Robert L. Cook, Joan S. Chmiel, Lisette Johnson, Xiuhong Li, Lisa P. Jacobson

Published in: AIDS and Behavior | Issue 1/2008

Abstract

We examined the influence of attitudes concerning HIV transmission, safe sex, and sexual sensation seeking, as well as negotiated risk reduction with primary partners, on the proportion of unprotected sexual partners (%UASP) among men who have sex with men (MSM). Participants were 263 HIV-seropositive and 238 HIV-seronegative MSM in the Multicenter AIDS Cohort Study between 1999 and 2003 who completed a 20-item attitude survey twice. Behavioral data were collected concurrently and 6–12 months after each survey. Among seropositives, decreased HIV concern and increased safer sex fatigue were associated with higher %UASP at 6 and 12 months. Among seronegatives, increased %UASP at 12 months was associated with safer sex fatigue. At 6 months and 12 months, risk reduction agreements were associated with increased %UASP among seronegatives in seroconcordant monogamous relationships, reflecting their abandonment of condoms in such partnerships. We conclude that HIV prevention efforts should target modifiable attitudes (reduced concern about HIV and safer sex fatigue) and increases in sexual risk-taking of MSM, particularly among HIV+ men having sex with serodiscordant partners.

Boily, M. C., Bastos, F. I., Desai, K., & Masse, B. (2004). Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models. Sexually Transmitted Diseases, 31, 100–113.CrossRefPubMed

Cairns, G. (2006). New directions in HIV prevention: Serosorting and universal testing. IAPAC Monthly, 12, 42–45.PubMed

Centers for Disease Control & Prevention. Special focus profiles: men who have sex with men. http://www.cdc.gov/std/stats/ (Accessed: 2003a).

Centers for Disease Control & Prevention (2003b). Trends in primary and secondary syphilis and HIV infections in men who have sex with men-San Francisco and Los Angeles, CA, 1998–2002. Morbidity and Mortality Weekly Report, 53, 575–578.

Centers for Disease Control & Prevention (2005). HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men–five U.S. cities, June 2004–April 2005. Morbidity and Mortality Weekly Report, 54, 597–601.

Crawford, J. M., Rodden, P., Kippax, S., & Van de Ven, P. (2001). Negotiated safety and other agreements between men in relationships: risk practice redefined. International Journal of STD & AIDS, 12(3), 164–170.CrossRef

Crawford, I., Hammack, P. L., McKirnan, D. J., Ostrow, D., Zamboni, B. D., Robinson, B., & Hope, B. (2003). Sexual sensation seeking, reduced concern about HIV and sexual risk behaviour among gay men in primary relationships. AIDS Care, 15, 513–524.CrossRefPubMed

Crepaz, N., Hart, T. A., & Marks, G. (2004). Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. Journal of the American Medical Association, 292, 224–236.CrossRefPubMed

Davidovich, U., de Wit, J. B., & Stroebe, W. (2000). Assessing sexual risk behaviour of young gay men in primary relationships: the incorporation of negotiated safety and negotiated safety compliance. AIDS, 14, 701–706.CrossRefPubMed

Diggle, P. J., K. Y. Liang, & S. L. Zeger (1995). Analysis of longitudinal data. New York, NY: Oxford University Press.

Elford, J., Bolding, G., & Sherr, L. (2002). High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism? AIDS, 16, 1537–1544.CrossRefPubMed

Francis, D. (1985). Presentation at National HIV Prevention for Gay Men Pre-Conference to the Third International AIDS Conference. Atlanta, GA.

Guzman, R., Colfax, G. N., Wheeler, S., Mansergh, G., Marks, G., Rader, M., & Buchbinder, S. (2005). Negotiated safety relationships and sexual behavior among a diverse sample of HIV-negative men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 38, 82–86.CrossRefPubMed

Hirshfield, S., Remien, R. H., Humberstone, M., Walavalkar, I., & Chiasson, M. A. (2004). Substance use and high-risk sex among men who have sex with men: a national online study in the USA. AIDS Care, 16, 1036–1047.CrossRefPubMed

International Collaboration on HIV Optimism (2003). HIV treatments optimism among gay men: an international perspective. Journal of Acquired Immune Deficiency Syndromes, 32, 545–550.CrossRef

Jacobson, L. P., Ostrow, D. G., Hylton, J., Gore, M. E., Weisberg, M., & Silvestre, A. (2004). Unsafe sexual behavior among homosexual men increases in the era of highly active antiretroviral therapy. 15th International AIDS Conference, Bangkok, Thailand.

Kalichman, S. C., Ramachandran, B., & Ostrow, D. (1998). Protease inhibitors and the new AIDS combination therapies: Implications for psychological services. Professional Psychology: Research & Practice, 29, 349–356.CrossRef

Kaslow, R. A., Ostrow, D. G., Detels, R., Phair, J. P., Polk, B. F., & Rinaldo, C. R. Jr. (1987). The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. American Journal of Epidemiology, 126, 310–318.PubMed

Kelly, J. A., Otto-Salaj, L. L., Sikkema, K. J., Pinkerton, S. D., & Bloom, F. R. (1998). Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention. Health Psychology, 17, 310–319.CrossRefPubMed

Kippax, S., Noble, J., Prestage, G., Crawford, J. M., Campbell, D., Baxter, D., & Cooper, D. (1997). Sexual negotiation in the AIDS era: negotiated safety revisited. AIDS, 11, 191–197.CrossRefPubMed

Mao, L., Crawford, J. M., Hospers, H. J., Prestage, G. P., Grulich, A. E., Kaldor, J. M., & Kippax, S. C. (2006). “Serosorting” in casual anal sex of HIV-negative gay men is noteworthy and is increasing in Sydney, Australia. AIDS, 20, 1204–1206.CrossRefPubMed

Morin, S. F., Vernon, K., Harcourt, J. J., Steward, W. T., Volk, J., Riess, T. H., Neilands, T. B., McLaughlin, M., & Coates, T. J. (2003). Why HIV infections have increased among men who have sex with men and what to do about it: findings from California focus groups. AIDS and Behavior, 7, 353–362.CrossRefPubMed

Odets, W. (1995). In the shadow of the epidemic: Being HIV-negative in the age of AIDS. Durham, NC: Duke University Press.

Ostrow, D., Fox, K., Kleeberger, C., Jacobson, L. P., Chmiel, J. S., Silvestre, A., Visscher, B. R., & Strathdee, S. A. (2001). Psychosocial correlates of incomplete adherence to HIV antiretroviral therapy (HAART): Mental health matters. 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL.

Ostrow, D. G., Cook, R. L., Sundaram, V., Cox, C., Qiao, W., Visscher, V., & Hylton, J. (2006). The setting of new or anonymous sexual encounters predicts risky sexual behavior and new sexually transmitted infections among MSM in the Multicenter AIDS Cohort Study (MACS). 16th International AIDS Conference, Toronto, Canada.

Ostrow, D. G., DiFranceisco, W., & Kalichman, S. C. (1997). Sexual adventurism, substance use, and high-risk sexual behavior: A structural modeling analysis of the Chicago MACS/coping and change cohort. AIDS and Behavior, 1, 191–202.CrossRef

Ostrow, D. G., Fox, K. J., Chmiel, J. S., Silvestre, A., Visscher, B. R., Vanable, P. A., Jacobson, L. P., & Strathdee, S. A. (2002). Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS, 16, 775–780.CrossRefPubMed

Ostrow, D. G., & Kalichman, S. C. (1999). Psychosocial and public health impacts of new HIV therapies. New York, NY: Kluwer/Plenum Academic Press.

Ostrow, D. G., McKirnan, D. J., & Vanable, P. A. (2005). The impact of new combination HIV therapies on knowledge, attitude and behaviors among Chicago gay men. 12th World AIDS Conference, Geneva, Switzerland.

Parsons, J. T., Schrimshaw, E. W., Wolitski, R. J., Halkitis, P. N., Purcell, D. W., Hoff, C. C., & Gomez, C. A. (2005). Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS, 19(Suppl 1), S13–S25.PubMedCrossRef

Scheer, S., Chu, P. L., Klausner, J. D., Katz, M. H., & Schwarcz, S. K. (2001). Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet, 357, 432–435.CrossRefPubMed

Shernoff, M. (2005). Without condoms: Unprotected sex, gay men & barebacking. New York, NY: Routledge.

Smith, S. M. (2005). New York City HIV superbug: fear or fear not? Retrovirology, 2, 14.CrossRefPubMed

Stephenson, J. M., Imrie, J., Davis, M. M., Mercer, C., Black, S., Copas, A. J., Hart, G. J., Davidson, O. R., & Williams, I. G. (2003). Is use of antiretroviral therapy among homosexual men associated with increased risk of transmission of HIV infection? Sexually Transmitted Infections, 79, 7–10.CrossRefPubMed

Stolte, I. G., de Wit, J. B., van Eeden, A., Coutinho, R. A., & Dukers, N. H. (2004). Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men. AIDS, 18, 1943–1949.CrossRefPubMed

Tongeren, J. V., & Madison, K. (2004). Partnering HIV treatment with HIV prevention. International Antiviral Therapy Evaluation Center (IATEC) Update 7.

Tun, W., Celentano, D. D., Vlahov, D., & Strathdee, S. A. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS, 17, 1953–1962.CrossRefPubMed

US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Rockville, MD: HIV/AIDS Treatment Information Service (Accessed: 10/29/2004) Available at: http://aidsinfo.nih.gov/guidelines.

Van de Ven, P., Crawford, J., Kippax, S., Knox, S., & Prestage, G. (2000). A scale of optimism-scepticism in the context of HIV treatments. AIDS Care, 12, 171–176.CrossRefPubMed

Van de Ven, P., Kippax, S., Knox, S., Prestage, G., & Crawford, J. (1999). HIV treatments optimism and sexual behaviour among gay men in Sydney and Melbourne. AIDS, 13, 2289–2294.CrossRefPubMed

Vanable, P. A., Ostrow, D. G., & McKirnan, D. J. (2003). Viral load and HIV treatment attitudes as correlates of sexual risk behavior among HIV-positive gay men. Journal of Psychosomatic Research, 54, 263–269.CrossRefPubMed

Vanable, P. A., Ostrow, D. G., McKirnan, D. J., Taywaditep, K. J., & Hope, B. A. (2000). Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health psychology, 19, 134–145.CrossRefPubMed

Wainberg, M. A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977–1983.CrossRefPubMed

Wilson, T., Feldman, J., Vega, M., Gandhi, M., Richardson, J., Cohen, M., McKaig, R., Ostrow, D., & Gange S. (2007). Acquisition of new sexual partners among women with HIV-infection: Patterns of disclosure and sexual behavior with new partnerships. AIDS Education and Prevention, 19, 151–159.

Xiridou, M., Geskus, R., De Wit, J., Coutinho, R., & Kretzschmar, M. (2003). The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam. AIDS, 17, 1029–1038.CrossRefPubMed

Title: Prospective Study of Attitudinal and Relationship Predictors of Sexual Risk in the Multicenter AIDS Cohort Study
Authors: David G. Ostrow
Michael J. Silverberg
Robert L. Cook
Joan S. Chmiel
Lisette Johnson
Xiuhong Li
Lisa P. Jacobson
Publication date: 01-01-2008
Publisher: Springer US
Published in: AIDS and Behavior / Issue 1/2008
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-007-9223-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2008

Substance Use and Sexual Behavior during Incarceration among 18- to 29-Year Old Men: Prevalence and Correlates

Consistent Condom Use Among Juvenile Detainees: The Role of Individual Differences, Social Bonding, and Health Beliefs

Moderating Effects of Age on the Alcohol and Sexual Risk Taking Association: An Online Daily Diary Study of Men Who have Sex with Men

Cognitive Executive Functioning in Relation to HIV Medication Adherence Among Gay, Bisexual, and other Men who have Sex with Men

Drinking and Condom use: Results from an Event-Based Daily Diary

HIV Treatment Adherence and Sexual Functioning

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials